Free Trial
NYSE:HUM

Humana (HUM) Stock Price, News & Analysis

Humana logo
$290.65 -0.65 (-0.22%)
Closing price 03:59 PM Eastern
Extended Trading
$293.05 +2.40 (+0.82%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Humana Stock (NYSE:HUM)

Advanced

Key Stats

Today's Range
$287.65
$292.00
50-Day Range
$246.89
$312.22
52-Week Range
$206.87
$315.35
Volume
791,906 shs
Average Volume
1.98 million shs
Market Capitalization
$34.96 billion
P/E Ratio
22.31
Dividend Yield
1.22%
Price Target
$297.58
Consensus Rating
Hold

Company Overview

Humana Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
85th Percentile Overall Score

HUM MarketRank™: 

Humana scored higher than 85% of companies evaluated by MarketBeat, and ranked 154th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Humana has received a consensus rating of Hold. The company's average rating score is 2.30, and is based on 8 buy ratings, 10 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Humana is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Humana has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Humana's stock forecast and price target.
  • Earnings Growth

    Earnings for Humana are expected to decrease by -20.28% in the coming year, from $16.47 to $13.13 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Humana is 22.31, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.16.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Humana is 22.31, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.83.

  • Price to Earnings Growth Ratio

    Humana has a PEG Ratio of 1.68. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Humana has a P/B Ratio of 2.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Humana's valuation and earnings.
  • Percentage of Shares Shorted

    2.75% of the float of Humana has been sold short.
  • Short Interest Ratio / Days to Cover

    Humana has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Humana has recently decreased by 19.12%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Humana pays a meaningful dividend of 1.23%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Humana does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Humana is 27.17%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Humana will have a dividend payout ratio of 26.96% next year. This indicates that Humana will be able to sustain or increase its dividend.

  • Read more about Humana's dividend.
  • Percentage of Shares Shorted

    2.75% of the float of Humana has been sold short.
  • Short Interest Ratio / Days to Cover

    Humana has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Humana has recently decreased by 19.12%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Humana has a news sentiment score of 0.77. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.64 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 25 news articles for Humana this week, compared to 30 articles on an average week.
  • Search Interest

    Only 32 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.
  • MarketBeat Follows

    Only 8 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Humana insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.37% of the stock of Humana is held by insiders.

  • Percentage Held by Institutions

    92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Humana's insider trading history.
Receive HUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HUM Stock News Headlines

What to Expect From Humana's Q3 2025 Earnings Report
NEW LAW: Congress Approves Setup For Digital Dollar?
Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor Green, it's a bill that contains "the entire setup, groundwork and infrastructure to move from cash to digital currency."tc pixel
CarePlus Announces Medicare Advantage Plan Offerings for 2026
Humana: Up 13% In A Week, Will HUM Stock Rally Continue?
See More Headlines

HUM Stock Analysis - Frequently Asked Questions

Humana's stock was trading at $253.71 on January 1st, 2025. Since then, HUM stock has increased by 14.6% and is now trading at $290.6550.

Humana Inc. (NYSE:HUM) announced its earnings results on Wednesday, July, 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by $0.05. The business's quarterly revenue was up 9.6% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Humana: Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and others.

Humana's top institutional shareholders include Allspring Global Investments Holdings LLC (0.80%), Voya Investment Management LLC (0.24%), Robeco Institutional Asset Management B.V. (0.18%) and VIRGINIA RETIREMENT SYSTEMS ET Al (0.16%). Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Timothy S Huval, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming.
View institutional ownership trends
.

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AUO (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
7/30/2025
Record date for 10/31 Dividend
9/26/2025
Ex-Dividend for 10/31 Dividend
9/26/2025
Today
10/24/2025
Dividend Payable
10/31/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:HUM
CIK
49071
Employees
65,680
Year Founded
1961

Price Target and Rating

High Price Target
$347.00
Low Price Target
$235.00
Potential Upside/Downside
+3.3%
Consensus Rating
Hold
Rating Score (0-4)
2.30
Research Coverage
20 Analysts

Profitability

EPS (Trailing Twelve Months)
$13.03
Trailing P/E Ratio
22.11
Forward P/E Ratio
17.48
P/E Growth
1.68
Net Income
$1.21 billion
Net Margins
1.28%
Pretax Margin
1.80%
Return on Equity
13.67%
Return on Assets
4.85%

Debt

Debt-to-Equity Ratio
0.69
Current Ratio
1.95
Quick Ratio
1.95

Sales & Book Value

Annual Sales
$117.76 billion
Price / Sales
0.29
Cash Flow
$23.90 per share
Price / Cash Flow
12.05
Book Value
$136.57 per share
Price / Book
2.11

Miscellaneous

Outstanding Shares
120,270,000
Free Float
119,827,000
Market Cap
$34.63 billion
Optionable
Optionable
Beta
0.42

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:HUM) was last updated on 10/24/2025 by MarketBeat.com Staff
From Our Partners